Finance

Lists
METROPOLIS:NSE
Metropolis Healthcare Ltd
₹537,45
+1,55%
(+8,20) 1D
12 Okt., 14:17:16 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for METROPOLIS...
Open
₹534,90
High
₹546,00
Low
₹534,30
Mkt. cap
111,46 mjd
Avg. vol.
253,21 k
Volume
113,68 k
Dividend
0,56%
Quarterly dividend
₹0,75
Ex-dividend date
19 Mei 2026
P/E ratio
55,35
52-wk high
₹609,05
52-wk low
₹412,25
EPS
₹9,71
No. of employees
4 k
Open
₹534,90
High
₹546,00
Low
₹534,30
Mkt. cap
111,46 mjd
Avg. vol.
253,21 k
Volume
113,68 k
Dividend
0,56%
Quarterly dividend
₹0,75
Ex-dividend date
19 Mei 2026
P/E ratio
55,35
52-wk high
₹609,05
52-wk low
₹412,25
EPS
₹9,71
No. of employees
4 k
News stories
From web sources and news partners
Profile
Metropolis Healthcare, also known as Metropolis Labs, is an Indian multinational chain of diagnostic labs, with its central laboratory in Mumbai, Maharashtra. Metropolis Healthcare has a chain of 124 clinical laboratories and 2400 collection centers across 7 countries including India. The healthcare company was founded in 1980. The company went public in April 2019. Wikipedia
About Metropolis Healthcare Ltd
CEOVijender Singh
Employees4,48 k
Founded1980
Headquarters-
SectorHealth care provider
Last report
05 Aug. 2026
Fiscal period
Q1 2027
₹2,73 / ₹2,65
+3,07%beat
Revenue / Est. (INR)
4,50 mjd / 4,46 mjd
+0,93%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
4,29 mjd
4,06 mjd
4,25 mjd
4,50 mjd
Cost of goods sold
877,48 m
792,37 m
1,27 mjd
871,01 m
Cost of revenue
877,48 m
792,37 m
1,27 mjd
871,01 m
Research and development expenses
49,67 m
80,57 m
43,07 m
63,30 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
953,93 m
942,25 m
2,92 mjd
1,07 mjd
Operating expense
2,66 mjd
2,64 mjd
2,28 mjd
2,84 mjd
Total operating expenses
3,53 mjd
3,43 mjd
3,55 mjd
3,71 mjd
Operating income
758,17 m
629,68 m
701,16 m
787,90 m
Other non operating income
8,91 m
90,16 m
-64,72 m
51,02 m
EBT including unusual items
710,26 m
571,57 m
697,63 m
777,12 m
EBT excluding unusual items
710,26 m
662,53 m
663,07 m
777,12 m
Income tax expense
181,36 m
150,70 m
188,03 m
208,29 m
Effective tax rate
25,53%
26,37%
26,95%
26,80%
Other operating expenses
1,33 mjd
1,30 mjd
-1,07 mjd
1,39 mjd
Net income
526,68 m
413,86 m
509,03 m
566,67 m
Net profit margin
12,27%
10,20%
11,99%
12,59%
Earnings per share
2,53
2,31
2,46
2,73
Interest and investment income
-
-
38,12 m
-
Interest expense
-56,82 m
-57,30 m
-79,33 m
-61,80 m
Net interest expenses
-56,82 m
-57,30 m
-41,21 m
-61,80 m
Depreciation and amortization charges
324,08 m
318,78 m
385,90 m
324,03 m
EBITDA
1,07 mjd
680,74 m
774,79 m
861,53 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme